Delivery Order SPE2DB24D3015-SPE2DB25FGAXM
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,063.67 to AmerisourceBergen Drug Corp for MIEBO 100% eye drops (3ml) on August 12, 2025, with an ultimate completion date of August 13, 2025. This firm fixed price delivery order was competitively awarded without a set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $14,193.62 to AmerisourceBergen Drug Corp for MIEBO 100% Eye Drop (3ml) on August 12, 2025, with completion scheduled for August 13, 2025. This firm fixed-price delivery order carries no set-aside designation and reflects a competitive award to the prime contractor. The product will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and operates as a...
- The Defense Logistics Agency awarded a delivery order valued at $5,957.57 to AmerisourceBergen Drug Corp for MIEBO 100% eye drop solution (3ml) on August 7, 2025, with an ultimate completion date of August 8, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $8,490.73 to AmerisourceBergen Drug Corp on September 4, 2025, for MIEBO 100% eye drop solution in 3ml quantities. The contract is a firm fixed price delivery order with performance in Conshohocken, Pennsylvania, and an ultimate completion date of September 5, 2025. This award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's capability to compete for federal pharmaceutical procurement...
- The Defense Logistics Agency awarded a $24,495 delivery order to AmerisourceBergen Drug Corp for MIEBO 100% eye drop product (3ML units) on July 25, 2025, with completion scheduled for July 28, 2025. This firm fixed price, competitively awarded contract carries no set-aside designation and will be performed at the vendor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical supplier to...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,527.73 to AmerisourceBergen Drug Corp for supply of Miebo 100% eye drops (3ml) on July 21, 2025, with completion expected by July 22, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as...
- The Defense Logistics Agency awarded a delivery order valued at $3,817.41 to AmerisourceBergen Drug Corp for MIEBO 100% eye drop solution (3ML) on August 29, 2025, with an ultimate completion date of September 2, 2025. This firm fixed price contract represents a non-set-aside competitive award and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfills...
- The Defense Logistics Agency awarded a delivery order valued at $3,795.08 to AmerisourceBergen Drug Corp for MIEBO 100% eye drop solution (3ml units) on July 29, 2025, with completion scheduled for July 30, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a...
- The Defense Logistics Agency awarded a delivery order valued at $11,460.42 to AmerisourceBergen Drug Corp for MIEBO 100% Eye Drop 3ML on September 8, 2025, with an ultimate completion date of September 9, 2025. This is a firm fixed price contract with no set-aside designation, meaning it was competitively awarded. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded a delivery order valued at $5,614.89 to AmerisourceBergen Drug Corp for MIEBO 100% eye drops (3 mL) on July 21, 2025, with completion scheduled for July 22, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in Conshohocken, PA 19428. This...
- SPE2DB24D3015Indefinite Delivery Contract
- SPE2DB24D3015-SPE2DB25FGAXMDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $21,186.61 to AmerisourceBergen Drug Corp for MIEBO 100% eye drops (3ml units) on September 10, 2025, with completion scheduled for September 11, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA's Medical Supply Chain. This delivery order is issued under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.99 billion prime contract vehicle running through December 2026. The IDC serves as a comprehensive global pharmaceutical support mechanism enabling the contractor to supply an extensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and medical devices. The DLA Troop Support Medical maintains this relationship as part of its strategic approach to pharmaceutical procurement, which includes planning for multiple regional awards under future Pharmaceutical Prime Vendor Global Program Generation V contracts.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $21.2k | 9/10/25 |